Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

RGNX REGENXBIO Inc

12.53

0.00 (0.00%)

Pre Market

Last Updated: 04:00:00

Delayed by 15 minutes

REGENXBIO doses first patient in early-stage Hunter Syndrome trial

To read the full story on Seeking Alpha, click here.

REGENXBIO (NASDAQ:RGNX)
Historical Stock Chart
From Aug 2024 to Sep 2024

Click Here for more REGENXBIO Charts.

REGENXBIO (NASDAQ:RGNX)
Historical Stock Chart
From Sep 2023 to Sep 2024

Click Here for more REGENXBIO Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

REGENXBIO Inc News

More REGENXBIO Inc News Articles

Impact Fusion (PK)

TransCode Therapeutics

Brookmount Explorations (PK)

Branded Legacy (PK)

NaturalShrimp (QB)

CyberFuels (PK)

Valiant Eagle (PK)

Enzolytics (PK)

1812 Brewing (PK)

Mullen Automotive

Healthier Choices Manage... (PK)

AMC Entertainment

Hannover House (PK)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions